The National Institutes of Health is offering the Innovation for HIV Vaccine Discovery Grant to support early discovery research on vaccine approaches to prevent acquisition or ongoing infection by HIV. This grant follows a Go/No-Go approach to funding high-risk research, with continued funding dependent on meeting predetermined criteria by the end of Year 2. Applications for this grant close on July 28, 2022.
Opportunity ID: 325934
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-20-158 |
| Funding Opportunity Title: | Innovation for HIV Vaccine Discovery (R01 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.855 — Allergy and Infectious Diseases Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Mar 31, 2020 |
| Last Updated Date: | Mar 31, 2020 |
| Original Closing Date for Applications: | Jul 28, 2022 |
| Current Closing Date for Applications: | Jul 28, 2022 |
| Archive Date: | Sep 02, 2022 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Independent school districts Small businesses Private institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled “Additional Information on Eligibility” for clarification) County governments Native American tribal governments (Federally recognized) For profit organizations other than small businesses City or township governments Public housing authorities/Indian housing authorities State governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Funding Opportunity Announcement (FOA) is to support high risk, high impact, early discovery research on vaccine approaches to prevent acquisition of or ongoing infection by HIV. In keeping with the high risk, high impact nature of this research, this FOA supports a Go/No-Go approach to funding high risk research, which is significantly different from most R01 projects. Continued funding for the full award duration is dependent upon achieving negotiated Go/No-Go criteria by the end of Year 2. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-20-158.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 325934 Full Announcement-PAR-20-158 -> PAR-20-158-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00262468 | Jun 29, 2020 | Jan 24, 2022 | View | |
| FORMS-G | Use for due dates on or after January 25, 2022 | PKG00269748 | Oct 28, 2021 | Jul 28, 2022 | View |
Package 1
Mandatory forms
325934 RR_SF424_2_0-2.0.pdf
325934 PHS398_CoverPageSupplement_5_0-5.0.pdf
325934 RR_OtherProjectInfo_1_4-1.4.pdf
325934 PerformanceSite_2_0-2.0.pdf
325934 RR_KeyPersonExpanded_2_0-2.0.pdf
325934 PHS398_ResearchPlan_4_0-4.0.pdf
325934 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
325934 RR_Budget_1_4-1.4.pdf
325934 RR_SubawardBudget30_1_4-1.4.pdf
325934 PHS398_ModularBudget_1_2-1.2.pdf
325934 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
325934 RR_SF424_5_0-5.0.pdf
325934 PHS398_CoverPageSupplement_5_0-5.0.pdf
325934 RR_OtherProjectInfo_1_4-1.4.pdf
325934 PerformanceSite_4_0-4.0.pdf
325934 RR_KeyPersonExpanded_4_0-4.0.pdf
325934 PHS398_ResearchPlan_4_0-4.0.pdf
325934 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
325934 RR_Budget_3_0-3.0.pdf
325934 RR_SubawardBudget30_3_0-3.0.pdf
325934 PHS398_ModularBudget_1_2-1.2.pdf
325934 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
